CERT

Certara, Inc.

16.44 USD

Last updated Dec 9, 11:48 UTC

Yesterday HIGH

$16.56

Yesterday LOW

$16.04

52w HIGH

$24.96

52w LOW

$11.81

EPS

0.11

PE

149.45

Next Earnings

Feb 28, 2024

Overview News Government Trades

Certara, Inc. stock is up 29.96% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 December’s closed higher than November. 0% of analysts rate it a buy.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Stock Exchange

NASDAQ

Sector

Services

Industry

Computer Software

Headquarters

-

Website

certara.com

Benzinga Newsdesk

Thu Aug 10, 2023

Credit Suisse Maintains Outperform on Certara, Lowers Price Target to $21

Credit Suisse analyst Dan Leonard maintains Certara (NASDAQ:CERT) with a Outperform and lowers the price target from $27 to $21.
Happy Mohamed

Wed Aug 9, 2023

Certara Sees FY23 EPS $0.44-$0.48 Vs $0.52 Est.; Revenue $345M-$360M Vs $377.16M Est.

2023 Financial Outlook Certara is updating its previously reported guidance for full year 2023. We expect the following: Full year 2023 revenue to be in the range of $345 million to $360
saritha@benzinga.com

Wed Aug 9, 2023

Certara Q2 Adj EPS $0.12 Misses $0.13 Estimate, Sales $90.45M Miss $92.18M Estimate

Certara (NASDAQ:CERT) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is a 33.33 percent increase over earnings of $0.09 per share from the same
Benzinga Insights

Wed Aug 9, 2023

Earnings Scheduled For August 9, 2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
Benzinga Newsdesk

Thu Jul 27, 2023

Morgan Stanley Maintains Equal-Weight on Certara, Raises Price Target to $22

Morgan Stanley analyst Vikram Malhorta maintains Certara (NASDAQ:CERT) with a Equal-Weight and raises the price target from $21 to $22.
Benzinga Insights

Mon May 22, 2023

Looking Into Certara's Return On Capital Employed
Happy Mohamed

Mon May 8, 2023

Certara Q1 EPS $0.12, Inline, Sales $90.30M Miss $90.99M Estimate

Certara (NASDAQ:CERT) reported quarterly earnings of $0.12 per share which met the analyst consensus estimate. This is a 9.09 percent increase over earnings of $0.11 per share from the same period last year. The company
Benzinga Insights

Mon May 8, 2023

Earnings Scheduled For May 8, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
Happy Mohamed

Thu Apr 27, 2023

Certara Customers Received 90% Of U.S. FDA Novel Drug Approvals For 9th Consecutive Year

Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that 90 percent of new drug approvals by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Review
Benzinga Insights

Wed Apr 12, 2023

Analyst Expectations for Certara's Future

UBS

Thu Dec 7, 06:08

hold

initial
Keybanc

Tue Dec 5, 06:17

hold

initial